Modulen IBD for Induction and Maintenance of Remission in Pediatric Crohn's Disease
Observational · No treatment assigned · Sites not listed yet · Assiut University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Crohn Disease, Inflammatory Bowel Diseases and Pediatric Crohns Disease. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Up to age 17
- Any sex
Some of the main requirements, copied from the record:
- \- Age younger than 18 years
- Diagnosis of Crohn's disease according to clinical, endoscopic, histopathological, and radiological findings
- Mild to moderate active Crohn's disease
Plus 2 more requirement(s). There are also 7 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 40 participants are expected to take part.
- Start date: 2026-09-10 (planned).
- Main results expected around 2027-09-10 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- Clinical remission rate after exclusive enteral nutrition (At week 6-8)
In the researchers’ words
This prospective cohort study aims to evaluate the effectiveness of the specially prepared medical milk formula (Modulen IBD) in inducing and maintaining remission in children and adolescents with Crohn's disease at Assiut University Children Hospital.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Crohn Disease; Inflammatory Bowel Diseases; Pediatric Crohns Disease |
| Lead sponsor | Assiut University |
| Enrollment | 40 (estimated) |
| Start date | 2026-09-10 |
| Primary completion (est.) | 2027-09-10 |
| First posted | 2026-09-16 |
| Last updated | 2026-09-16 |
| Official title | Effectiveness of a Specially Prepared Medical Milk Formula for Induction and Maintenance of Remission in Pediatric Crohn's Disease |
| ClinicalTrials.gov ID | NCT07821645 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * \- Age younger than 18 years * Diagnosis of Crohn's disease according to clinical, endoscopic, histopathological, and radiological findings * Mild to moderate active Crohn's disease * Newly diagnosed or active patients commencing Exclusive Enteral Nutrition therapy * Written informed consent from parents or legal guardians Exclusion Criteria: * \- Age 18 years or older * Severe complicated Crohn's disease requiring immediate surgery * Other chronic gastrointestinal diseases * Severe systemic illnesses affecting nutritional status * Inability to tolerate enteral nutrition * Poor compliance with Modulen therapy * Incomplete follow-up data
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.